Please login to the form below

Not currently logged in
Email:
Password:

Therachon appoints Christian Meyer as chief medical officer

He succeeds Maarten Kraan who remains as an advisor

Christian MeyerTherachon has appointed Christian Meyer as its new chief medical officer, a role that will see him succeed Maarten Kraan, who will remain as an advisor to the company.

Meyer joins the biotech from uniQure B.V where he was chief medical officer and has held several similar roles for Cardoz, Symphogen, Zymenex and Novo Nordisk.

Luca Santarelli, chief executive officer and director, Therachon, said: Christian has spent over fifteen years in the biotechnology sector, leading high performing global teams in clinical development, pharmacovigilance, regulatory and medical affairs from early stage development through to commercialisation.

“His entrepreneurial drive and successful track record in executing drug development and regulatory strategies in rare diseases will be an asset to Therachon as we continue to grow as a company.”

4th September 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics